PD27 Budget Impact Analysis Of The High-Dose Trivalent Influenza Vaccine For The Brazilian Unified Health System

Introduction Influenza is an acute infectious disease that is highly transmissible and affects the respiratory system. It impacts the health system and society by reducing a patient’s productivity and quality of life. The population group most susceptible to complications and death is adults older than 65 years and children younger than five years. Methods The analysis was performed from the perspective of the Unified Health System (SUS) as the funder. The eligible population was estimated based on epidemiological data from population projections by the Brazilian Institute of Geography and Statistics for a five-year time horizon. The assumption of 90 percent vaccination coverage was adopted as market share. Analyses were performed by scenarios that varied market share and added costs with clinical benefits. Costs were estimated on a national basis, considering the price of the technology, inputs, and waste. Hospitalization costs and their confidence intervals were obtained from the SUS Hospitalization Authorization database. Results The cost of vaccination with the high-dose trivalent influenza vaccine was estimated at USD119,637,999.04 in the first year and USD657,405,529.68 over a five-year time horizon. The increase in the budget was USD104,034,983.12 in the first year and USD571,747,563.22 over five years. The alternative scenario one was estimated considering vaccination coverage in 2023 of 63.3 percent, obtaining an incremental impact of USD72,824,488.19 in the first year and USD400,167,351.63 in five years. Alternative scenario two considered the reduction in hospitalizations and found an incremental impact of USD103,908,194.74 in the first year and USD570,970,948.59 in five years. Conclusions The budgetary impact was estimated at over USD571 million in five years. In absolute numbers, the reduction in hospitalizations due to influenza (0.4%) and pneumonia (0.3%) was not very significant, which generated a reduction in the incremental budgetary impact, in relation to the main scenario of the analysis, of 0.02 percent in the first year and 0.13 percent in five years.

Authors

Publication Details

Journal
International Journal of Technology Assessment in Health Care
Published
2025-12-01
DOI
https://doi.org/10.1017/s0266462325101621
Primary Topic
Influenza Virus Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

PD27 Budget Impact Analysis Of The High-Dose Trivalent Influenza Vaccine For The Brazilian Unified Health System

Carlos Magliano, Ricardo J. Fernandes, Katia Senna, Bernardo Tura et al.
International Journal of Technology Assessment in Health Care
Influenza Virus Research Studies
article

PD27 Budget Impact Analysis Of The High-Dose Trivalent Influenza Vaccine For The Brazilian Unified Health System

Carlos Magliano, Ricardo J. Fernandes, Katia Senna, Bernardo Tura, Marisa Santos, Márcia Gisele Costa
article en

Abstract

Introduction Influenza is an acute infectious disease that is highly transmissible and affects the respiratory system. It impacts the health system and society by reducing a patient’s productivity and quality of life. The population group most susceptible to complications and death is adults older than 65 years and children younger than five years. Methods The analysis was performed from the perspective of the Unified Health System (SUS) as the funder. The eligible population was estimated based on epidemiological data from population projections by the Brazilian Institute of Geography and Statistics for a five-year time horizon. The assumption of 90 percent vaccination coverage was adopted as market share. Analyses were performed by scenarios that varied market share and added costs with clinical benefits. Costs were estimated on a national basis, considering the price of the technology, inputs, and waste. Hospitalization costs and their confidence intervals were obtained from the SUS Hospitalization Authorization database. Results The cost of vaccination with the high-dose trivalent influenza vaccine was estimated at USD119,637,999.04 in the first year and USD657,405,529.68 over a five-year time horizon. The increase in the budget was USD104,034,983.12 in the first year and USD571,747,563.22 over five years. The alternative scenario one was estimated considering vaccination coverage in 2023 of 63.3 percent, obtaining an incremental impact of USD72,824,488.19 in the first year and USD400,167,351.63 in five years. Alternative scenario two considered the reduction in hospitalizations and found an incremental impact of USD103,908,194.74 in the first year and USD570,970,948.59 in five years. Conclusions The budgetary impact was estimated at over USD571 million in five years. In absolute numbers, the reduction in hospitalizations due to influenza (0.4%) and pneumonia (0.3%) was not very significant, which generated a reduction in the incremental budgetary impact, in relation to the main scenario of the analysis, of 0.02 percent in the first year and 0.13 percent in five years.

International Journal of Technology Assessment in Health CareVol. 41(S1)
Good health and well-being
Openalex Percentile: Top 29%
Influenza Virus Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

PD27 Budget Impact Analysis Of The High-Dose Trivalent Influenza Vaccine For The Brazilian Unified Health System — Carlos Magliano, Ricardo J. Fernandes, et al. · International Journal of Technology Assessment in Health Care (2025) | TGRS Research Map | TGRS